share holdings, page-15

@ds Something else that will add to the number of small shareholders in Anteo is the researchers and scientists that are increasingly being exposed to this technology since August last year.

To elaborate further...

Anteo's new AMG products have only been commercially available for several months now ... Before the release of these products, it would have been a rare occurrence for the average researcher to stumble across this technology. My discovery came early on from Twinvest. During this time, it was an ABSOLUTE NIGHTMARE to find an actual decent scientific description of how this product worked. I imagine that for most other researchers un-involved with stocks, they would have had very low chance of exposure to this technology and Anteo in general... until recently...

The ball has started rolling

Anteo has now released multiple very cheap generic products that can be easily implemented into existing systems by most biologics researchers. This is Anteo's golden ticket that will indirectly market awareness of their technology to the researchers in Australia, Europe and the US through recently formed distribution networks with OWL and Gennova Researchers have an innate curiosity of how things work, and buying these products will result in researchers actively seeking information on the underlying fundamentals of this surface chemistry. Combine this innate curiosity with Anteo's outstanding marketing ability and you have a product that is very likely to penetrate the market and eventually sell itself once the ball picks up enough speed.

I'd also like to share a story of How to Market your products like a boss!

Our laboratory received a parcel of new commercially available products. Unexpectedly, the parcel contents included marketing wizardry in the form of additional 10c scientific gift products. These small tokens gained instant popularity and temporarily threw our laboratory into a frenzy. I had to take a step back and watch fellow researchers battle it out with scissor-paper-rock to claim these additional products, and I was partly devastated that I didn't get one...

This hilarious frenzy eventuated into something more serious that I have not observed before. All researchers in view halted work and entered into a 30 minute discussion on potential applications this product will directly have on our work. Colleagues were mind blown by how this simple invention could solve lingering problems, save us time, reduce stress and allow savings on generic consumables that we use by the hundreds-thousands. Some of the innovations that people collectively rationalized during this short time-frame even brought a new light to my own understanding of implications outside of my narrow areas of research.

As consequence of this experience, I believe that if this technology can establish in the biologics market we will see a self-sustaining technology fuelled mainly by it's own popularity. The applications are too obvious and too simple. The cost savings and the time savings are significant. And the ability to simplify experiments and relieve stress is invaluable, something that is under-rated in Anteo's explanation of M&G key benefits.

Disclaimer:This is not financial advice. DYOR. It may even pay to get in contact with researchers you know and trust and ask them for a product analysis and unbiased opinion. Furthermore, myself and the company I work for are not involved in any commercial agreements in any way.